APPLICATION
ANDA211031
TYPE
ANDA
ORIGINAL APPROVAL
2019-02-21
LATEST ACTION
2022-06-15
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
EXEMESTANEPrescription
EXEMESTANE 25MG · TABLET · ORAL
Approval history
2022-06-15Labeling · Supplement 3 · standardAP
2019-02-21UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.